Loading data for GPCR — first visit, this takes a few seconds.

Structure Therapeutics In...

NasdaqGM: GPCR · Real-Time Price · USD
49.78
+0.77 (1.57%)
At close: Aug 21, 2026, 8:00 PM

The price, the headline numbers and the latest news, in one place.

Structure Therapeutics Inc. (GPCR) Stock Price, Analysis & Data

1.57%

No data available

Bid36.54
Market Cap3.5B
Revenue (ttm)n/a
Net Income (ttm)-214.84M
-1.51
-3.03
n/a
-23.21
P/B (ttm)2.58
P/S (ttm)n/a
Earnings DateNov 5, 2026
Ask64
Volume207,022
Avg. Volume (20D)714,473
Open49.65
Previous Close49.01
Day's Range49.59 - 51.02
52-Week Range18.26 - 94.90
Analystn/a
Price Targetn/a
Dividendsn/a
Ex-Dividend Daten/a

About GPCR

Structure Therapeutics Inc., a clinical stage global biopharmaceutical company, develops and delivers novel oral small molecule therapeutics to treat various chronic diseases with unmet medical needs in the United States. Its lead product candidate is GSBR-1290, an oral and biased small molecule agonist of glucagon-like-peptide-1 receptor, which is in two phase 2 clinical trials for the treatment of obesity, overweight, and related conditions. Th...

Industry Biotechnology
Sector Healthcare
IPO Date Feb 3, 2023
Employees 281
Stock Exchange NasdaqGM
Ticker Symbol GPCR
Full Company Profile

Financial Performance

In 2025, Structure Therapeutics's revenue was 0, an increase of undefined% compared to the previous year's 0. Earnings were -141.2M, an increase of 15.24%.

Financial Statements

Earnings Surprise

Structure Therapeutics has released their quarterly earnings on Aug 6, 2026:
  • Revenue of $0 misses estimates by $0, with NaN% YoY growth.
  • EPS of -0.49 misses estimates by -0.11, with -36.11% YoY decline.
Structure Therapeutics Inc. is scheduled to release its earnings on Nov 5, 2026, during market hours.
Analysts project revenue of ... Upgrade





Page 1 of 2